[Form 4] Children's Place, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Umair Muhammad, President and Interim CEO of The Children’s Place, Inc. (PLCE), was granted 160,000 restricted stock units (RSUs) effective August 20, 2025. The RSUs were authorized July 8, 2025 and based on the Company’s closing stock price of $5.00 on that date. One-third of the underlying shares may be delivered on May 28, 2027, May 30, 2028 and May 25, 2029, provided Mr. Muhammad remains employed on each vesting date. After the grant, Mr. Muhammad beneficially owns 270,524 shares. The Form 4 was signed by an attorney-in-fact on August 22, 2025.

Positive

• 160,000 RSU grant to the President and Interim CEO aligns executive compensation with shareholder value
• Multi-year vesting schedule (May 28, 2027; May 30, 2028; May 25, 2029) supports retention through 2029
• Grant authorization and pricing disclosed: authorized July 8, 2025 and based on $5.00 closing price

Negative

• 160,000 underlying shares increase potential outstanding shares upon vesting, which could dilute existing shareholders
• No performance-based vesting disclosed; vesting is purely time-based and conditioned only on continued employment

Insights

Financial Analyst

TL;DR: Executive awarded 160,000 RSUs with multi-year vesting; modest near-term dilution and retention focus.

The grant of 160,000 restricted stock units to the President and Interim CEO ties compensation to equity value and includes time-based vesting over three dates in 2027–2029, which supports retention incentives. The award was authorized July 8, 2025 using the $5.00 closing price and finalized August 20, 2025. Beneficial ownership after the grant is 270,524 shares as reported. From a capital-structure view, these are future deliverable shares subject to continued employment; no exercise price or derivative terms are reported beyond the RSU mechanics.

Corporate Governance Expert

TL;DR: Time-based RSU grant is standard for executive retention; disclosure is straightforward and complete.

The Form 4 discloses a customary restricted stock unit grant under the 2011 Equity Incentive Plan with explicit vesting dates tied to continued employment. The filing identifies Mr. Muhammad’s roles as Director and President and Interim CEO and provides the authorization and pricing basis used for the award. The disclosure meets Section 16 reporting requirements and was executed by an attorney-in-fact on August 22, 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Umair Muhammad

(Last) (First) (Middle)

C/O THE CHILDREN'S PLACE, INC.

500 PLAZA DRIVE

(Street)

SECAUCUS NJ 07094

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Childrens Place, Inc. [ PLCE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT AND INTERIM CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.10 per share	08/20/2025		A		160,000(1)	A	$0	270,524	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Common Stock, par value $0.10 per share, of The Children's Place, Inc. (the "Company"), underlying restricted stock units granted under the Company's 2011 Equity Incentive Plan (the "Plan") on August 20, 2025, one third of which may be deliverable to Mr. Umair on May 28, 2027, May 30, 2028 and May 25, 2029, provided Mr. Umair is employed by the Company on the respective vesting dates, subject to the terms and conditions of the Plan. The Company authorized the grant of the underlying shares on July 8, 2025 and as a result, these shares are granted based on the closing stock price of $5.00 on that date, subject to the finalization of the restricted stock unit agreements which occurred on August 20, 2025.

	/s/ Jared Shure, as Attorney-in-Fact for Muhammad Umair	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did PLCE report on the Form 4?

The Form 4 reports a grant of 160,000 restricted stock units (RSUs) to Umair Muhammad, President and Interim CEO, with an effective date of 08/20/2025.

When do the RSUs vested or become deliverable?

One-third of the underlying shares may be delivered on May 28, 2027, May 30, 2028, and May 25, 2029, provided Mr. Muhammad remains employed on each vesting date.

How many shares does Mr. Umair beneficially own after the reported transaction?

Following the reported transaction, Mr. Umair beneficially owns 270,524 shares.

What price was used to determine the grant?

The grant was based on the Company’s closing stock price of $5.00 on July 8, 2025, when the Company authorized the grant.

Who signed the Form 4 filing and when?

The Form 4 was signed by /s/ Jared Shure, as Attorney-in-Fact for Muhammad Umair on 08/22/2025.